THERAPY OF PATIENTS SUFFERING FROM PANCREATIC DIABETES COMBINED WITH CENTRAL NERVOUS SYSTEM DAMAGE Russian patent published in 2009 - IPC A61K31/44 A61N1/36 A61P25/28 

FIELD: medicine.

SUBSTANCE: invention refers to medicine and covers therapy of patients suffering from pancreatic diabetes combined with central nervous system damage. The therapy involves intravenous infusion of Mexidol 5% 5.0 ml. In 30-35 minutes, the patient is exposed to transcerebral sinusoidal current of frequency 5000 Hz, modulated low-frequency oscillation with using fronto-occipital technique. The half-period duration is 1:1.5 in variable mode, III operation mode, modulation depth 75%, frequency 30 Hz. Current strength within 0.8 to 2.0 mA is dosed to sensation of easy, painless vibration. Duration of procedures is 15 minutes in therapeutic course 8-10 daily procedures.

EFFECT: method allows reducing frequency and intensity of headaches, degree of manifestation of depression and anxiety, improving state of health, memory, attention, cerebral circulation and putting the patient in good spirit, normalising sleep and blood lipids.

2 ex